Nicotine Oral Dissolvable Thin Films Market size was valued at USD 0.10 billion in 2023. The Nicotine Oral Dissolvable Thin Films Market industry is projected to grow from USD 0.11 billion in 2024 to USD 0.15 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.86% during the forecast period (2024 - 2032).
Increasing smoking and tobacco cessation efforts and advantages of oral thin film are the major factors driving the global nicotine oral thin films market
.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Significant demand for nicotine oral dissolvable thin films is being driven by increased efforts to quit smoking, which is speeding up market expansion in a number of ways. People are being actively encouraged to stop smoking or cut back on their nicotine use by public health campaigns and government programs, such as those led by the Office on Smoking and Health (OSH). Programs aimed at reducing tobacco use aid in these endeavors by offering tools and resources for the execution of successful quit strategies.
Furthermore, the benefits of oral thin film (OTF) technology are significant factors driving the global nicotine oral dissolvable thin film market. Below are a few key benefits that contribute to market growth. OTFs dissolve quickly in the mouth and do not require water, making them a convenient and portable method of nicotine delivery. Users can use them discreetly at any time and from any location. For instance, Nicoccino (Sweden): Lemon Mint and Menthol Strong manufacture next generation oral nicotine which provides: This type of delivery system is typically designed to provide rapid nicotine absorption into the bloodstream, providing a quick-acting effect for users who require immediate nicotine delivery. Such rapid-release formulations are useful in situations requiring immediate relief or satisfaction, such as smoking cessation products or nicotine replacement therapies. These strips are extremely thin, measuring only 0.07 mm, ensuring a comfortable appearance and sensation for users. They dissolve within a few minutes of use, leaving no residue to dispose of, making them both convenient and environmentally friendly. This feature not only improves the user experience by maintaining discretion, but it also aligns with sustainability objectives by reducing waste.
In conclusion, increased smoking cessation efforts play a critical role in driving demand for nicotine oral dissolvable thin films, resulting in significant market growth as more people embrace healthier alternatives to smoking. Further, the growing awareness of the health risks associated with traditional smoking creates a demand for alternative nicotine delivery systems such as OTFs. This expanding market opportunity is driving growth in the global nicotine oral dissolvable thin film market.
Based on strength, the Nicotine Oral Dissolvable Thin Films Market has been segmented into 1mg, 2mg and others. The 2mg segment held the largest market share in 2023 and the same segment is the fastest-growing segment during the forecast period (2024 -2032). The 2 mg strength is ideal for moderate and heavy smokers, providing a balanced dose to effectively manage cravings. With an increased focus on smoking cessation and harm reduction, these innovative products provide a discreet and effective alternative for nicotine delivery. Rising public awareness of the health risks associated with traditional smoking methods is driving consumer demand. Furthermore, advances in drug formulation technology and a wider range of flavors are improving the user experience. As regulatory landscapes evolve and more smokers seek alternatives, the nicotine oral dissolvable thin film market is expected to expand, providing lucrative opportunities for both manufacturers and investors.
Based on route of administration, the Nicotine Oral Dissolvable Thin Films Market has been bifurcated into tongue and buccal. The tongue segment held the largest market share in 2023, and the same segment is the fastest-growing segment during the forecast period (2024 -2032). The tongue route of administration method offers rapid nicotine absorption directly through the oral mucosa, providing quick relief from cravings. The convenience and discreet nature of tongue-administered films make them an attractive option for users. Increasing awareness of smoking cessation aids and advancements in thin film technology are key drivers of this growth. As the demand for effective and easy nicotine replacement therapies rises, the market for nicotine oral dissolvable thin films is expected to expand substantially in the coming years.
FIGURE 2: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on age group, the Nicotine Oral Dissolvable Thin Films Market has been segmented into adults and adolescents. The adults segment held the largest market share in 2023, and the same segment is the fastest-growing segment during the forecast period (2024 -2032). The global market for nicotine oral dissolvable thin films aimed at adults is expanding rapidly due to increased awareness of nicotine replacement therapy (NRT) and a shift towards less harmful smoking alternatives. These films appeal to both smokers and vapers because they provide a discreet and convenient way to manage nicotine cravings. Rising smoking cessation efforts, favourable regulations, advancements in film technology, improvement in bioavailability and user experience, are driving the market growth. Furthermore, expanding e-commerce platforms and shifting consumer preferences towards innovative NRT solutions contribute to market expansion. As public health initiatives focus on reducing tobacco use, nicotine oral dissolvable thin films are poised for continued expansion. For instance, In April 2024, the UK's Royal College of Physicians (RCP) stated that nicotine replacement therapy (NRT) is most effective in helping people quit smoking when used in conjunction with health professional input and support, but much less so when used alone.
Based on sales channel, the Nicotine Oral Dissolvable Thin Films Market has been segmented into online, and offline. The offline segment held the largest market share in 2023, and the online segment is the fastest-growing segment during the forecast period (2024 -2032). Online sales channels have significantly enhanced market accessibility, allowing consumers to easily purchase nicotine oral thin films products worldwide. E-commerce platforms play a crucial role in market penetration, offering a seamless shopping experience. As awareness of smoking-related health issues rises, the demand for nicotine oral dissolvable thin films through online sales channels is expected to continue growing, supporting sustained market expansion.
The North America Nicotine Oral Dissolvable Thin Films Market accounted for USD 31.20 million in 2023 and is projected to grow at a CAGR of 3.86% during the forecast period. North America is further segmented into the US and Canada. The North America nicotine oral dissolvable thin films market is experiencing significant growth driven by increasing awareness of smoking cessation aids and the rising prevalence of smoking-related health issues. The Centers for Disease Control and Prevention (CDC) launched the first-ever federally funded national tobacco education campaign, Tips. The Tips Campaign's goals are to raise public awareness of the immediate health consequences of smoking and secondhand smoke exposure, as well as to encourage adults who smoke, to quit and provide free help which will increase the demand for nicotine related products.
Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.
FIGURE 3: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Europe Nicotine Oral Dissolvable Thin Films Market accounted for USD 44.48 million in 2023 and is projected to grow at a CAGR of 3.46% during the forecast period. Europe is further segmented into the Germany, France, UK, Italy, Spain, Italy and Rest of the Europe.
The Europe nicotine oral dissolvable thin films market is poised for significant growth in the coming years, driven by rising popularity of nicotine oral dissolvable thin films and presence of market players. With health-conscious consumers seeking less harmful options for smoking cessation, oral thin films provide a discreet and convenient way to consume nicotine without the adverse effects associated with traditional smoking. Furthermore, regulatory support across various European countries is also fostering innovation and expanding the market as manufacturers are investing to develop new flavors and formulations to appeal to diverse consumer preferences. In March 2024, AdhexPharma S.A.S has announced the acquisition of Tesa Labtec GmbH. With this acquisition, AdhexPharma, a leading pharmaceutical company that develops cutting-edge drug delivery systems and oral thin films, joins forces with tesa Labtec GmbH, a well-known CDMO that provides formulation, development, and contract manufacturing services for transdermal and topical patches, as well as buccal and sublingual films. This acquisition will boost research and development activity related to oral thin films while also strengthening the company's presence in Germany. The Germany nicotine oral dissolvable thin films market held the largest market share in 2023 and is the fastest-growing market in the Europe region.
The Asia-pacific Nicotine Oral Dissolvable Thin Films Market accounted for USD 20.74 million in 2023 and is projected to grow at a CAGR of 4.77% during the forecast period. Asia-Pacific is further segmented into the China, India, Japan, South Korea, Australia, and Rest of Asia-Pacific. The Asia-Pacific nicotine oral dissolvable thin films market is experiencing significant growth due to increasing health awareness, urbanization, and high smoking prevalence in countries like China, South Korea, India, and Japan. According to the American Medical Association, China, India, and Indonesia will account for half of the world's male smokers by 2024. Japan and Bangladesh are also among the ten countries with the highest smoking rates. Asia is among the world's largest tobacco consumers, and it is expected to create an opportunity for nicotine products in the coming years. Moreover, China nicotine oral dissolvable thin films market held the largest market share in 2023, and India nicotine oral dissolvable thin films market is the fastest growing market in the Asia-Pacific region.
The global nicotine dissolvable oral thin films market is distinguished by the presence of numerous global and local players catering to nicotine oral dissolvable thin films products that are evolving at a rapid pace. Furthermore, the rising R&D activities and increasing awareness and demand for smoking cessation aids are further driving the growth of Nicotine Oral Dissolvable Thin Films Market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs.
The global nicotine dissolvable oral thin films market is highly fragmented, with players competing, partnering, and investing heavily in research and development to gain a significant market share. The market is moderately fragmented with rising competition, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.
Nissha Co., Ltd. is a Japanese company that operates globally, specializing in 3 businesses of Industrial Materials, Devices and Medical Technologies, and other businesses. They specialize in delivering high-quality, value-added products within the medical devices and related markets, aimed at promoting healthy and prosperous lifestyles. Their current offerings include contract design and development manufacturing services tailored for leading medical device manufacturers, primarily in North America and Europe. Their product range spans surgical instruments for minimally invasive medical procedures and medical wearable sensors designed for diverse therapeutic applications. Additionally, they produce and distribute proprietary branded products directly to medical institutions. Moreover, in April 2023, the company’s coating machine has been authorized for shipment. This machine marks the initial stage in the production of Nicoccino's nicotine strips, generating raw film material on a roll.
February 2023: Nicoccino has commenced its international expansion. During this phase, the company's nicotine strips were distributed to two new distributors. In Malta, the product was introduced in approximately twelve pharmacies in November. In Estonia, sales will be handled through Nicorex, a distributor specializing in tobacco-free nicotine products, which operates 20 proprietary stores. The launch is anticipated in the first quarter.
August 2023: Nicoccino's nicotine strips are among the eight finalists in the small business category of the Gama Innovation Awards. This global competition celebrates innovators in the fast-moving consumer goods sector.
June 2023: Zim Laboratories Limited announced key investments in Australia and the MENA region to increase its position in developed and emerging markets. Its board has approved an investment in a local start-up to improve registration, marketing, distribution, and sales capabilities for New Innovative Products (NIP) and Oral Thin Films (OTF).
North America
Europe
Asia-Pacific
Rest of the World
Middle East
Africa
South America
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.10 billion |
| Market Size 2024 | USD 0.11 billion |
| Market Size 2032 | USD 0.15 billion |
| Compound Annual Growth Rate (CAGR) | 3.86% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2019 to 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Strength, Route of Administration, Age Group, Sales Channel, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, Australia. |
| Key Companies Profiled | Â Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) |
| Key Market Opportunities | Initiative to build and launch oral thin film manufacturing Innovation associated with nicotine oral thin film |
| Key Market Drivers | Increasing smoking and tobacco cessation efforts Advantages of oral thin film |
Frequently Asked Questions (FAQ) :
The Nicotine Oral Dissolvable Thin Films Market is anticipated to reach 0.15 billion by 2032 at a CAGR of 3.86% during the forecast period of 2024-2032.
The US held 87.60% share of North America for nicotine oral dissolvable thin films market in 2023.
The Nicotine Oral Dissolvable Thin Films Market is expected to grow at a 3.86% CAGR during the forecast period from 2024 to 2032.
The North America region market held the largest market share in the Nicotine Oral Dissolvable Thin Films Market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
